CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis

C3 Glomerulopathy (C3G) and Immune Complex-Mediated Membranoproliferative glomerulonephritis (IC-MPGN) are rare diseases characterized by glomerular deposition of C3 caused by dysregulation of the alternative pathway (AP) of complement. In approximately 20% of affected patients, dysregulation is dri...

Full description

Bibliographic Details
Main Authors: Rossella Piras, Matteo Breno, Elisabetta Valoti, Marta Alberti, Paraskevas Iatropoulos, Caterina Mele, Elena Bresin, Roberta Donadelli, Paola Cuccarolo, Richard J. H. Smith, Ariela Benigni, Giuseppe Remuzzi, Marina Noris
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.670727/full
_version_ 1818898103923638272
author Rossella Piras
Matteo Breno
Elisabetta Valoti
Marta Alberti
Paraskevas Iatropoulos
Caterina Mele
Elena Bresin
Roberta Donadelli
Paola Cuccarolo
Richard J. H. Smith
Ariela Benigni
Giuseppe Remuzzi
Marina Noris
author_facet Rossella Piras
Matteo Breno
Elisabetta Valoti
Marta Alberti
Paraskevas Iatropoulos
Caterina Mele
Elena Bresin
Roberta Donadelli
Paola Cuccarolo
Richard J. H. Smith
Ariela Benigni
Giuseppe Remuzzi
Marina Noris
author_sort Rossella Piras
collection DOAJ
description C3 Glomerulopathy (C3G) and Immune Complex-Mediated Membranoproliferative glomerulonephritis (IC-MPGN) are rare diseases characterized by glomerular deposition of C3 caused by dysregulation of the alternative pathway (AP) of complement. In approximately 20% of affected patients, dysregulation is driven by pathogenic variants in the two components of the AP C3 convertase, complement C3 (C3) and Factor B (CFB), or in complement Factor H (CFH) and Factor I (CFI), two genes that encode complement regulators. Copy number variations (CNVs) involving the CFH-related genes (CFHRs) that give rise to hybrid FHR proteins also have been described in a few C3G patients but not in IC-MPGN patients. In this study, we used multiplex ligation-dependent probe amplification (MLPA) to study the genomic architecture of the CFH-CFHR region and characterize CNVs in a large cohort of patients with C3G (n = 103) and IC-MPGN (n = 96) compared to healthy controls (n = 100). We identified new/rare CNVs resulting in structural variants (SVs) in 5 C3G and 2 IC-MPGN patients. Using long-read single molecule real-time sequencing (SMRT), we detected the breakpoints of three SVs. The identified SVs included: 1) a deletion of the entire CFH in one patient with IC-MPGN; 2) an increased number of CFHR4 copies in one IC-MPGN and three C3G patients; 3) a deletion from CFHR3-intron 3 to CFHR3-3′UTR (CFHR34–6Δ) that results in a FHR3-FHR1 hybrid protein in a C3G patient; and 4) a CFHR31–5-CFHR410 hybrid gene in a C3G patient. This work highlights the contribution of CFH-CFHR CNVs to the pathogenesis of both C3G and IC-MPGN.
first_indexed 2024-12-19T19:26:45Z
format Article
id doaj.art-bf5651269e7640a2b06033b39950716b
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-19T19:26:45Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-bf5651269e7640a2b06033b39950716b2022-12-21T20:08:45ZengFrontiers Media S.A.Frontiers in Genetics1664-80212021-06-011210.3389/fgene.2021.670727670727CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GlomerulonephritisRossella Piras0Matteo Breno1Elisabetta Valoti2Marta Alberti3Paraskevas Iatropoulos4Caterina Mele5Elena Bresin6Roberta Donadelli7Paola Cuccarolo8Richard J. H. Smith9Ariela Benigni10Giuseppe Remuzzi11Marina Noris12Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyMolecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, Iowa City, IA, United StatesIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, ItalyC3 Glomerulopathy (C3G) and Immune Complex-Mediated Membranoproliferative glomerulonephritis (IC-MPGN) are rare diseases characterized by glomerular deposition of C3 caused by dysregulation of the alternative pathway (AP) of complement. In approximately 20% of affected patients, dysregulation is driven by pathogenic variants in the two components of the AP C3 convertase, complement C3 (C3) and Factor B (CFB), or in complement Factor H (CFH) and Factor I (CFI), two genes that encode complement regulators. Copy number variations (CNVs) involving the CFH-related genes (CFHRs) that give rise to hybrid FHR proteins also have been described in a few C3G patients but not in IC-MPGN patients. In this study, we used multiplex ligation-dependent probe amplification (MLPA) to study the genomic architecture of the CFH-CFHR region and characterize CNVs in a large cohort of patients with C3G (n = 103) and IC-MPGN (n = 96) compared to healthy controls (n = 100). We identified new/rare CNVs resulting in structural variants (SVs) in 5 C3G and 2 IC-MPGN patients. Using long-read single molecule real-time sequencing (SMRT), we detected the breakpoints of three SVs. The identified SVs included: 1) a deletion of the entire CFH in one patient with IC-MPGN; 2) an increased number of CFHR4 copies in one IC-MPGN and three C3G patients; 3) a deletion from CFHR3-intron 3 to CFHR3-3′UTR (CFHR34–6Δ) that results in a FHR3-FHR1 hybrid protein in a C3G patient; and 4) a CFHR31–5-CFHR410 hybrid gene in a C3G patient. This work highlights the contribution of CFH-CFHR CNVs to the pathogenesis of both C3G and IC-MPGN.https://www.frontiersin.org/articles/10.3389/fgene.2021.670727/fullC3 glomerulopathy (C3G)immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN)factor H (FH)factor H-related proteins (FHRs)complementcopy number variations (CNVs)
spellingShingle Rossella Piras
Matteo Breno
Elisabetta Valoti
Marta Alberti
Paraskevas Iatropoulos
Caterina Mele
Elena Bresin
Roberta Donadelli
Paola Cuccarolo
Richard J. H. Smith
Ariela Benigni
Giuseppe Remuzzi
Marina Noris
CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
Frontiers in Genetics
C3 glomerulopathy (C3G)
immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN)
factor H (FH)
factor H-related proteins (FHRs)
complement
copy number variations (CNVs)
title CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
title_full CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
title_fullStr CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
title_full_unstemmed CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
title_short CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
title_sort cfh and cfhr copy number variations in c3 glomerulopathy and immune complex mediated membranoproliferative glomerulonephritis
topic C3 glomerulopathy (C3G)
immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN)
factor H (FH)
factor H-related proteins (FHRs)
complement
copy number variations (CNVs)
url https://www.frontiersin.org/articles/10.3389/fgene.2021.670727/full
work_keys_str_mv AT rossellapiras cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT matteobreno cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT elisabettavaloti cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT martaalberti cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT paraskevasiatropoulos cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT caterinamele cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT elenabresin cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT robertadonadelli cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT paolacuccarolo cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT richardjhsmith cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT arielabenigni cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT giusepperemuzzi cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT marinanoris cfhandcfhrcopynumbervariationsinc3glomerulopathyandimmunecomplexmediatedmembranoproliferativeglomerulonephritis